Factors influencing breath condensate volume

Abstract

Analysis of breath condensate (BC) has received interest recently due to the need for easy and repetitive monitoring of airway and pulmonary disease. While many authors have used custom built systems, commercial systems are now available and will probably be used more widely. Early studies of markers and mediators in BC have reported concentrations following varying periods of sampling time. However, factors that influence the generation of BC have not been analysed and it is unclear whether breathing rate, tidal volume, lung function, body weight, height or age influence the amount of BC collected. We therefore studied the influence of these factors on breath condensate volume and breath condensate urea and protein concentrations in 22 healthy volunteers and 23 COPD patients.

A strong correlation of total respired volume and breath condensate volume was observed for both groups (volunteers: r = 0.952, p < 0.0001, COPD: r = 0.883, p < 0.0001) while no significant correlation existed for breath condensate volume and TLC, RV, VC, FEV1, R_tot, height or body weight. As long as ventilation remained fairly constant, breath condensate volume increased linearly with time. The fraction of breath condensate extracted from total vapour contained in the exhalate was estimated by measuring relative atmospheric humidity before and after the collecting tube. The amount calculated by the change in temperature and saturation corresponded closely to the amount actually collected.

We conclude from these results that breath condensate volume is primarily dependent on V_E, and does not seem to depend on lung function parameters. For standardisation it is suggested to report breath condensate measurements per volume respired. Both, urea and protein are present in measurable quantities in breath condensate and protein as well as BCV may be helpful denominators for comparison with e. g. cytokines in lung disease.

References

• 1 Montuschi P, Kharitonov S A, Ciabattoni G, Corradi M, van Rensen L, Geddes D M, Hodson M E, Barnes P J. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis.  Thorax. 2000;  55 (3) 205-209
• 2 Hunt J F, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mills T A, Gaston B. Endogenous airway acidification. Implications for asthma pathophysiology.  Am J Respir Crit Care Med. 2000;  161 (3 Pt 1) 694-699
• 3 Loukides S, Horvath I, Wodehouse T, Cole P J, Barnes P J. Elevated levels of expired breath hydrogen peroxide in bronchiectasis.  Am J Respir Crit Care Med. 1998;  158 (3) 991-994
• 4 Gessner C, Seyfarth H J, Hoheisel G, Winkler J, Hillebrand T, Schauer J. Identification of K-ras gene mutations in breathing condensate of patients with non small cell lung cancer (NSCLC) as a non-invasive method for screening (abstract).  Am J Respir Crit Care Med. 1998;  157 A693
• 5 Gessner C. Detection of mutations of the K-ras gene in condensed breath of patients with non-small-cell lung carcinoma (NSCLC) as a possible noninvasive screening method.  Pneumologie. 1998;  52(7) 426-427
• 6 Hillebrand T, Bendzko P, Beck E, Becher G, Roth M, Neubauer G, Norpoth K, Stresemann E. Isolation of DNA from breathing condensate (abstract).  Am J Respir Crit Care Med. 1996;  153 A181
• 7 Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov S A, Barnes P J. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients.  Am J Respir Crit Care Med. 1999;  160 (1) 216-220
• 8 Becher G, Winsel K, Beck E, Neubauer G, Stresemann E. Breath condensate as a method of noninvasive assessment of inflammation mediators from the lower airways.  Pneumologie. 1997;  51 (Supp 2) 456-459
• 9 Antczak A, Nowak D, Bialasiewicz P, Kasielski M. Hydrogen peroxide in expired air condensate correlates positively with early steps of peripheral neutrophil activation in asthmatic patients.  Arch Immunol Ther Exp (Warsz). 1999;  47(2) 119-126
• 10 Dekhuijzen P N, Aben K K, Dekker I, Aarts L P, Wielders P L, van Herwaarden C L, Bast A. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1996;  154 (3 Pt 1) 813-816
• 11 Horvath I, Loukides S, Wodehouse T, Kharitonov S A, Cole P J, Barnes P J. Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.  Thorax. 1998;  53 (10) 867-870
• 12 Kietzmann D, Kahl R, Muller M, Burchardi H, Kettler D. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS.  Intensive Care Med. 1993;  19 (2) 78-81
• 13 Sznajder J I, Fraiman A, Hall J B, Sanders W, Schmidt G, Crawford G, Nahum A, Factor P, Wood L D. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure.  Chest. 1989;  96 (3) 606-612
• 14 Nowak D, Antczak A, Krol M, Pietras T, Shariati B, Bialasiewicz P, Jeczkowski K, Kula P. Increased content of hydrogen peroxide in the expired breath of cigarette smokers.  Eur Respir J. 1996;  9 (4) 652-657
• 15 Scheideler L, Manke H G, Schwulera U, Inacker O, Hammerle H. Detection of nonvolatile macromolecules in breath.  A possible diagnostic tool? Am Rev Respir Dis. 1993;  148 (3) 778-784
• 16 Haslam P L, Baughman R P. Report of ERS Task Force: Guidelines for measurement of acellular components and standardization of BAL [editorial].  Eur Respir J. 1999;  14 (2) 245-248
• 17 von Vogel H U. Chemiker-Kalender, 1th ed. Springer-Verlag, Berlin, Göttingen,Heidelberg 1956
• 18 Smith P K, Krohn R I, Hermanson G T, Mallia A K, Gartner F H, Provenzano M D, Fujimoto E K, Goeke N M, Olson B J, Klenk D C. Measurement of protein using bicinchoninic acid.  Anal Biochem. 1985;  150 (1) 76-85
• 19 Wiechelman K J, Braun R D, Fitzpatrick J D. Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation.  Anal Biochem. 1988;  175 (1) 231-237
• 20 Reinhold P, Langenberg A, Becher G, Rothe M. Breath condensate - a medium obtained by a noninvasive method for the detection of inflammation mediators of the lung.  Berl Munch Tierarztl Wschr. 1999;  112 (6-7) 254-259